Cargando…
PTBP1 as a Promising Predictor of Poor Prognosis by Regulating Cell Proliferation, Immunosuppression, and Drug Sensitivity in SARC
BACKGROUND: Sarcomas (SARC) have been found as rare and heterogeneous malignancies with poor prognosis. PTBP1, belonging to the hnRNPs family, plays an essential role in some biological functions (e.g., pre-mRNA splicing, cell growth, and nervous system development). However, the role of PTBP1 in SA...
Autores principales: | Gong, Haiyi, Jiang, Aimin, Jiang, Runyi, Wang, Yao, Zhang, Dan, Wu, Zhipeng, Xiao, Jianru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151003/ https://www.ncbi.nlm.nih.gov/pubmed/35651729 http://dx.doi.org/10.1155/2022/5687238 |
Ejemplares similares
-
Retracted: PTBP1 as a Promising Predictor of Poor Prognosis by Regulating Cell Proliferation, Immunosuppression, and Drug Sensitivity in SARC
por: Longevity, Oxidative Medicine and Cellular
Publicado: (2023) -
Comparing SARC-CalF With SARC-F for Screening Sarcopenia in Adults With Type 2 Diabetes Mellitus
por: Xu, Zeru, et al.
Publicado: (2022) -
Sarcopenia for predicting mortality among elderly nursing home residents: SARC-F versus SARC-CalF
por: Yang, Ming, et al.
Publicado: (2019) -
The usefulness of SARC-F
por: Piotrowicz, Karolina, et al.
Publicado: (2021) -
PTBP1 is a Novel Poor Prognostic Factor for Glioma
por: Liu, Pan, et al.
Publicado: (2022)